Jan Spanholtz Selected Research

Jan Spanholtz Research Topics

14	Neoplasms (Cancer) 10/2021 - 02/2010
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 01/2016
2	Leukemia 01/2014 - 01/2013
1	Cytokine Release Syndrome 09/2021
1	Melanoma (Melanoma, Malignant) 09/2021
1	Residual Neoplasm 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Central Nervous System Neoplasms 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2017
1	Body Weight (Weight, Body) 08/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Infections 05/2014
1	B-Cell Leukemia (Leukemia, B Cell) 01/2014
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2013

3	Cetuximab (Erbitux)FDA Link 01/2017 - 01/2016
2	ErbB Receptors (EGF Receptor)IBA 10/2021 - 01/2016
2	Fc Receptors (Fc Receptor)IBA 02/2021 - 01/2016
2	CytokinesIBA 08/2017 - 07/2015
2	Immunoglobulin G (IgG)IBA 01/2017 - 01/2016
2	Monoclonal AntibodiesIBA 01/2017 - 01/2016
1	Single-Domain AntibodiesIBA 10/2021
1	LigandsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021
1	micaIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	peptide AIBA 01/2021
1	AntigensIBA 01/2020
1	ChemokinesIBA 01/2020
1	Panitumumab (Vectibix)FDA Link 01/2016
1	Rituximab (Mabthera)FDA Link 01/2014
1	Interleukin-12 (IL 12)IBA 01/2014
1	Interleukin-15 (Interleukin 15)IBA 01/2013

9	Therapeutics 10/2021 - 01/2014
5	Immunotherapy 02/2021 - 02/2010
3	Drug Therapy (Chemotherapy) 02/2021 - 01/2013
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2021
1	Radiotherapy 02/2021
1	Stem Cell Transplantation 01/2014